Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.
For long-term stability, I trust KSquare’s NPS guidance. Their regular insights and personal approach are top-notch.
I’m thankful to KSquare for making the NPS onboarding so smooth. Their resources are easy to understand for non-finance people.
The fund selection process at KSquare is simple yet thorough. Their insights helped me diversify properly and reduce risk effectively. Very pleased!
As an NRI, I felt disconnected from Indian financial options. KSquare’s services changed that. Everything is efficient and built around my needs.
With KSquare, SIP investments have become a habit I enjoy. They offer flexibility, insights, and a clean interface. Truly made investing part of my routine.
KSquare provided a practical solution without liquidating my investments. I’m grateful for their clarity and quick process.
KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.
I always feared medical emergencies, but KSquare helped us prepare financially. The SIP plan ensures liquidity when required. Now health issues don’t create financial panic anymore. Truly thoughtful solutions.
Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.
FAQ's
Frequenlty Asked Question
What is a New Fund Offering (NFO) in mutual funds?
A New Fund Offering is the first-time subscription launch of a new mutual fund scheme by an asset management company.
Can I invest in mutual funds online through KSquare?
Yes, KSquare’s digital platform allows you to browse, select, and invest in mutual funds entirely online.
Can I invest in an NFO online with KSquare?
Yes, KSquare’s digital platform enables secure and quick online investments in NFOs with just a few clicks.
Can NRIs invest in NFOs via KSquare?
Yes, most NFOs are open to NRIs subject to fund house guidelines. KSquare helps confirm eligibility for NRIs.
Are SIP investments safe?
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.
How does KSquare help with mutual fund selection?
KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.
Are returns from mutual funds taxable for NRIs?
Yes, returns are subject to TDS based on fund type and holding period. KSquare helps you plan for this.
Is there a lock-in period for mutual fund investments?
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.